Relapsed Small Lymphocytic Lymphoma

Also known as: Small Lymphocytic Lymphoma, Relapsed

DrugDrug NameDrug Description
DB11952DuvelisibAn inhibitor of phosphatidylinositol 3-kinase delta and gamma used to treat relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
DB09054IdelalisibAn antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL).
DB16582Lisocabtagene maraleucelA CAR T-cell therapy for treatment resistant or more severe B-cell lymphomas.
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide2Active Not Recruiting1
DB01073Fludarabine2Active Not Recruiting2
DB01042Melphalan2Active Not Recruiting1
DB00688Mycophenolate mofetil2Active Not Recruiting1
DB00877Sirolimus2Active Not Recruiting1
DB17366MB-102 CD123 CARNot AvailableEnrolling by Invitation1